Genetic testing and early diagnosis and intervention: boon or burden?
- 1 April 1996
- journal article
- Published by BMJ in Journal of Medical Ethics
- Vol. 22 (2) , 105-110
- https://doi.org/10.1136/jme.22.2.105
Abstract
The possibility of early diagnosis and intervention is radically changed by the advent of genetic testing. The recent report of the Nuffield Council on Bioethics is timely and helpful. I have suggested, that not only the severity of the disability indicated by genetic information, and the accuracy of the data, ought to govern the approach to the implementation of screening for genetic disorders. In addition, assessment of the value of the information to those involved should be considered. The efficacy of the available therapeutic measures, combined with the prognostic data are important indices of the value of the information. These measures fall into three categories and thus indicate that three different courses of intervention may be appropriate. Three approaches to diagnosis and intervention are then outlined, drawing on the experience of various clinical initiatives.Keywords
This publication has 9 references indexed in Scilit:
- Risks of cancer in BRCA1-mutation carriersThe Lancet, 1994
- The Last Well PersonNew England Journal of Medicine, 1994
- The Right to Health in International Human Rights LawHealth and Human Rights, 1994
- Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.1993
- Reproductive Technology and the Commodification of LifeWomen & Health, 1988
- A private view of heterozygosity: Eight‐year follow‐up study on carriers of the Tay‐Sachs gene detected by high school screening in montrealAmerican Journal of Medical Genetics, 1984
- ETHICAL ISSUES IN GENETIC SCREENING AND ANTENATAL DIAGNOSISClinical Obstetrics and Gynecology, 1981
- Genetics and the Law IIPublished by Springer Nature ,1980
- An Almost Absolute Value in HistoryPublished by Harvard University Press ,1970